Nurse Practitioner, Family · Oldsmar, FL
NPI
1619536158
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3771 Tampa Rd
Oldsmar, FL, 34677
Phone (866) 389-2727
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
2,057 services
Medicare patients, 2024
320
Average age 77
Drug cost, 2024
$155K
1,850 prescriptions
Company payments, 2025
$1,585
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elise Helmbrecht was code 99214 (office e&m - established), 365 times for 312 patients. In total Elise Helmbrecht billed 2,057 services in 16 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 365 | 312 | $85.35 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 332 | 294 | $11.00 | $3,653 |
| 81003 Clinical Chemistry | Office | 327 | 286 | $2.20 | $719 |
| 51798 Ultrasound - Nonspecific | Office | 302 | 274 | $8.57 | $2,587 |
| 36415 Venipuncture Blood Collection | Office | 15 | 14 | $8.65 | $130 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 15 | 15 | $39.50 | $593 |
By year: 2022 $7,560 for 165 services; 2023 $3,668 for 96 services; 2024 $45K for 2,057 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 327 | 286 | $2.20 | $719 |
| 36415 Venipuncture Blood Collection | 15 | 14 | $8.65 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Elise Helmbrecht prescribed most often to Medicare patients was Tamsulosin Hcl, with 740 prescriptions and refills. In total Elise Helmbrecht wrote 1,850 Medicare prescriptions that cost $155K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 740 | 2,049 | 296 | $13K |
| Cefdinir Generic | 242 | 332 | 168 | $6,926 |
| Solifenacin Succinate Generic | 143 | 406 | 65 | $12K |
| Myrbetriq Mirabegron | 83 | 163 | 28 | $72K |
| Finasteride Generic | 63 | 174 | 20 | $1,004 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 59 | 61 | 49 | $953 |
| Ciprofloxacin Hcl Generic | 53 | 53 | 46 | $387 |
| Oxybutynin Chloride Generic | 49 | 124 | 19 | $798 |
| Gemtesa Vibegron | 39 | 59 | Under 11 | $27K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 35 | 37 | 23 | $136 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 35 | 103 | 15 | $1,603 |
| Testosterone Cypionate Generic | 34 | 79 | 15 | $2,301 |
| Doxycycline Hyclate Generic | 24 | 24 | 23 | $248 |
| Bethanechol Chloride Generic | 23 | 52 | Under 11 | $1,231 |
| Cephalexin Generic | 20 | 48 | Under 11 | $631 |
Brand drugs: 144 claims; generic drugs: 1,706 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elise Helmbrecht $1,585 ($1,585 in general payments such as food, travel and fees) from 18 companies. The largest payer was Teleflex LLC with $364.
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC TFX | 4 | $364 |
| Abbvie Inc. ABBV | 5 | $209 |
| Sumitomo Pharma America, Inc. 4506.T | 7 | $157 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $128 |
| Endo USA, Inc. | 1 | $123 |
| Tolmar, Inc. | 4 | $96.23 |
| Boston Scientific Corporation BSX | 3 | $82.42 |
| Janssen Biotech, Inc. JNJ | 3 | $71.77 |
| Merck Sharp & Dohme LLC MRK | 3 | $66.43 |
| Accord Healthcare, Inc. | 2 | $59.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.